Trial · NCT02048215
Effect on Energy Metabolism at Cellular Level of Diet Plus Treatment With Ephedrine and Caffeine in Obesity
NCT02048215, Phase 3, Completed, Istituto Auxologico Italiano
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effect on Energy Metabolism at Cellular Level of Diet Plus Treatment With Ephedrine and Caffeine in Obesity. Trials, record NCT02048215. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02048215
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effect on Energy Metabolism at Cellular Level of Diet Plus Treatment With Ephedrine and Caffeine in Obesity
- NCT number
- NCT02048215
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 13 participants, actual
- Lead sponsor
- Istituto Auxologico Italiano
- Conditions
- Obesity
- Interventions
- Caffeine, Placebo, Ephedrine, Hypocaloric diet
- First posted
- 2014-01-29
- Last updated
- 2014-01-29
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in resting energy expenditure | Baseline and 1 month | Resting energy expenditure is measured by indirect calorimetry |
| Secondary | Blood pressure monitoring | Baseline and daily for 30 days (t.i.d.) | |
| Secondary | Electrocardiograpic monitoring | Baseline and at week 2,3,4 | |
| Secondary | Cardiac ultrasound monitoring | Baseline and at week 2,3,4 | Cardiac ultrasound measurement for assessing possible detrimental changes |
| Secondary | Changes in fasting glucose | Baseline and at one month | Patients are assessed by oral glucose tolerance test at baseline and following one month of treatment, with assessment of glucose, insulin, free-fatty acids and glycerol |
| Secondary | Changes in fasting insulin | baseline and one month | Patients are assessed by oral glucose tolerance test at baseline and following one month of treatment, with assessment of glucose, insulin, free-fatty acids and glycerol |
| Secondary | Changes in fasting free fatty acids | baseline ans one month | Patients are assessed by oral glucose tolerance test at baseline and following one month of treatment, with assessment of glucose, insulin, free-fatty acids and glycerol |
| Secondary | Changes in fasting glycerol | baseine and one month | Patients are assessed by oral glucose tolerance test at baseline and following one month of treatment, with assessment of glucose, insulin, free-fatty acids and glycerol |
| Secondary | Changes in thyroid function (TSH, T3, T4) | Baseline and 1 month | |
| Secondary | Changes in plasma noradrenalin | Baseline and 1 month |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers16
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02048215
GET https://conductscience.org/api/trials/v1/NCT02048215/registered